Shares of Hikma Pharmaceuticals PLC HIK rallied 1.05% to £20.14 Thursday, on what proved to be an all-around favorable ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.35% to £19.82 Friday, on what proved to be an all-around favorable ...

Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,922.34 ($24.05) ...

In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K.

The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...

Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...

Most readers would already be aware that Hikma Pharmaceuticals' (LON:HIK) stock increased significantly by 5.3% over the past month. As most would know, fundamentals are what usually guide market ...

In this article, we are going to take a look at where Hikma Pharmaceuticals PLC (LON:HIK.L) stands against the other U.K. dividend aristocrats. In recent years, investors have turned away from UK ...

( MENAFN - Mid-East Info) Amman, Jordan: Hikma Pharmaceuticals PLC (Hikma, Group), the multinational Pharmaceutical group, ...

Hikma Pharmaceuticals announced a transaction involving the disposal of shares by a Person Discharging Managerial Responsibilities (PDMR), Susan Ringdal. The transaction involved the sale of 3,300 ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...